Sales Growth YoY (Last Twelve Months): LB Corp (LBRX)

Graphic logo of LB Corp (LBRX)

LB Pharmaceuticals Inc is implementing energy-efficient filtration systems to comply with environmental standards. This chart on GURU.Markets shows that the TTM revenue growth rate exhibits a specific trend, where the 0.00 level serves as a critical benchmark. Patents for psychotropic drugs provide a steady cash generator, while the launch of final trials for the LB-102 drug enhances the therapy's safety profile.

LBRX (LB Pharmaceuticals, Inc.) Revenue Growth YoY (Last 12 Months) history from 11/23/2025 to 11/17/2026

LB Pharmaceuticals (LBRX) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:LBRX (LB Corp)
Finished products of lbpharma.us

From a portfolio management perspective, this indicator captures the rolling year revenue dynamics, allowing for an assessment of business scaling rates via the percentage change in income. However, for LB Pharmaceuticals Inc (LBRX), the annual sales growth rate (trailing 12 months) remains static or zero, as the clinical trial stage precludes commercial revenue, shifting the analytical focus from sales growth to capital burn efficiency.